Cost effectiveness of antiretrovirals - long term or short term?
Flessa
Steffen
S
University of Greifswald, Greifswald, Germany. steffen.flessa@unigreifswald.de
D044966:Anti-Retroviral Agents / Q000191:economics; D023241:Antiretroviral Therapy, Highly Active / Q000191:economics*; D003362:Cost-Benefit Analysis; D015658:HIV Infections / Q000188:drug therapy* / Q000191:economics; D006801:Humans; D019057:Quality-Adjusted Life Years
D044966:Anti-Retroviral Agents